BE882669A - Methode de detection du cancer - Google Patents

Methode de detection du cancer

Info

Publication number
BE882669A
BE882669A BE0/200139A BE200139A BE882669A BE 882669 A BE882669 A BE 882669A BE 0/200139 A BE0/200139 A BE 0/200139A BE 200139 A BE200139 A BE 200139A BE 882669 A BE882669 A BE 882669A
Authority
BE
Belgium
Prior art keywords
detection method
cancer detection
cancer
detection
Prior art date
Application number
BE0/200139A
Other languages
English (en)
French (fr)
Inventor
L Galvan
S Crooke
Original Assignee
Bristol Myers St
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers St filed Critical Bristol Myers St
Publication of BE882669A publication Critical patent/BE882669A/fr

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57411—Specifically defined cancers of cervix
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/52—Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5308—Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G01N33/57488—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds identifable in body fluids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6875—Nucleoproteins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4703—Regulators; Modulating activity
    • G01N2333/4704—Inhibitors; Supressors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/475—Assays involving growth factors
    • G01N2333/50—Fibroblast growth factors [FGF]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Sink And Installation For Waste Water (AREA)
  • Investigating Or Analyzing Materials By The Use Of Ultrasonic Waves (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
BE0/200139A 1979-04-10 1980-04-04 Methode de detection du cancer BE882669A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US2873279A 1979-04-10 1979-04-10

Publications (1)

Publication Number Publication Date
BE882669A true BE882669A (fr) 1980-10-06

Family

ID=21845111

Family Applications (1)

Application Number Title Priority Date Filing Date
BE0/200139A BE882669A (fr) 1979-04-10 1980-04-04 Methode de detection du cancer

Country Status (24)

Country Link
JP (1) JPS55143441A (sv)
KR (1) KR830002502A (sv)
AR (1) AR222700A1 (sv)
AT (1) AT365343B (sv)
AU (1) AU536522B2 (sv)
BE (1) BE882669A (sv)
CH (1) CH644453A5 (sv)
DE (1) DE3013837A1 (sv)
DK (1) DK149980A (sv)
ES (1) ES490396A0 (sv)
FI (1) FI801078A (sv)
FR (1) FR2454099A1 (sv)
GB (1) GB2047712B (sv)
GR (1) GR67692B (sv)
HU (1) HU183122B (sv)
IE (1) IE49981B1 (sv)
IL (1) IL59772A (sv)
IT (1) IT1143135B (sv)
LU (1) LU82345A1 (sv)
NL (1) NL8002094A (sv)
NO (1) NO801018L (sv)
PH (1) PH15637A (sv)
SE (1) SE8002602L (sv)
ZA (1) ZA802141B (sv)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3524644A1 (de) * 1985-07-10 1987-01-15 Heyl Chem Pharm Undulin und dessen peptidfragmente, verfahren zu deren herstellung und ihre verwendung

Also Published As

Publication number Publication date
AU536522B2 (en) 1984-05-10
AU5719380A (en) 1980-10-16
GB2047712B (en) 1983-02-23
FR2454099B1 (sv) 1984-01-27
HU183122B (en) 1984-04-28
IE800693L (en) 1980-10-10
NL8002094A (nl) 1980-10-14
DK149980A (da) 1980-10-11
FI801078A (fi) 1980-10-11
GB2047712A (en) 1980-12-03
DE3013837A1 (de) 1980-10-30
ZA802141B (en) 1981-04-29
SE8002602L (sv) 1980-12-09
ES8103380A1 (es) 1981-02-16
ATA195780A (de) 1981-05-15
AT365343B (de) 1982-01-11
IT1143135B (it) 1986-10-22
NO801018L (no) 1980-10-13
ES490396A0 (es) 1981-02-16
IT8048370A0 (it) 1980-04-09
KR830002502A (ko) 1983-05-30
FR2454099A1 (fr) 1980-11-07
GR67692B (sv) 1981-09-07
IE49981B1 (en) 1986-01-22
IL59772A (en) 1983-05-15
AR222700A1 (es) 1981-06-15
PH15637A (en) 1983-03-11
IL59772A0 (en) 1980-06-30
JPS55143441A (en) 1980-11-08
CH644453A5 (fr) 1984-07-31
LU82345A1 (fr) 1980-12-16

Similar Documents

Publication Publication Date Title
BE866875A (nl) Detectiestelsel
ES501130A0 (es) Procedimiento de obtencion de mucopolisacaridos
NO151778C (no) Sikteapparat
FI802300A (fi) Anordning foer fastspaenning av roerformiga lindningskaernor
DK408080A (da) Testilbehandlingsmiddel
SE8005123L (sv) Enzymimmunologisk bestemningsmetod
FR2468470B3 (fr) Tireuse de surimpression
BR8002682A (pt) Magnetomero de regiao portadora
BE881928A (fr) Bouclier
BR8007927A (pt) Conjunto de avanco
FR2471028B1 (fr) Blindage anti-neutrons
BR8006437A (pt) Guarnicao de calafetagem
AR219208A1 (es) Recuperacion de metacroleina
BE882669A (fr) Methode de detection du cancer
IT1149902B (it) Antiipertensivi chinazolinici
IT1194657B (it) Apparato elaboratore di segnali
DK176780A (da) Cancerdiagnosticeringsfremgangsmaade
IT1212406B (it) Reagenti alogenati
DK86980A (da) Vindue
DK503280A (da) Vindue
BR7807695A (pt) Metodo de deteccao de antibiotico
SE7909606L (sv) Detekteringsforfarande
FR2352533A1 (fr) Procede de detection du cancer
IT1136062B (it) Apparecchio cianografico
BE874157A (fr) Detecteur ionique

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: BAYLOR COLLEGE OF MEDICINE

Effective date: 19870430